TScan Therapeutics, Inc. (TCRX): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in TCRX · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
7
13F filers
Aggregate Value
$9.3M
Across holders
Last Price
$0.80
2026-08-24
Sector
Health Care
GICS
Quarterly fund activity4 increased2 reduced0 exited
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP CIK 0001263508 | Hedge Fund | 2.78M | $2.7M | 29.4% | 0.0% | Unchanged | +$0 | Q2 2026 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 1.95M | $1.9M | 20.6% | 0.0% | Added | +$726K | Q2 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 1.33M | $1.3M | 14.0% | 0.0% | Reduced | $-37K | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 1.16M | $1.1M | 12.3% | 0.0% | Reduced | $-291K | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 1.01M | $989K | 10.7% | 0.0% | Added | +$818K | Q2 2026 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 687K | $674K | 7.3% | 0.0% | Added | +$441K | Q2 2026 |
| SHAW D E & CO INC CIK 0001009207 | Hedge Fund | 548K | $537K | 5.8% | 0.0% | Added | +$194K | Q2 2026 |
Unchanged
Hedge Fund
$2.7M· 29.4% of total· 0.0% port· 2.78M sh· +$0 QoQ· Q2 2026
Added
Hedge Fund
$1.9M· 20.6% of total· 0.0% port· 1.95M sh· +$726K QoQ· Q2 2026
Reduced
Hedge Fund
$1.3M· 14.0% of total· 0.0% port· 1.33M sh· $-37K QoQ· Q2 2026
Reduced
Hedge Fund
$1.1M· 12.3% of total· 0.0% port· 1.16M sh· $-291K QoQ· Q2 2026
Added
Hedge Fund
$989K· 10.7% of total· 0.0% port· 1.01M sh· +$818K QoQ· Q2 2026
Added
Hedge Fund
$674K· 7.3% of total· 0.0% port· 687K sh· +$441K QoQ· Q2 2026
Added
Hedge Fund
$537K· 5.8% of total· 0.0% port· 548K sh· +$194K QoQ· Q2 2026
Loading recent insider activity…